Japanese Pharmaceutical Market, 2006-2011

Questions: Discounts, Updates etc.

Pages: 124

Price (Single): £1,499

Price (Departmental): £2,999

Price (Company): £4,999

Publication Date: 2006-01-24

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market. However, it is a market that frustrates the major pharmaceutical companies as it is growing at a significantly lower rate of growth than the average of the world pharmaceutical markets.

Historically this has been attributed to the struggling Japanese economy, but more recently the biennial NHI drug price reductions have been the determining factor of the Japanese pharmaceutical market. As the Japanese government seeks to stimulate further industrial growth, it must adopt policies that also continue to restrict the overall health expenditure.

Pivotal period of change

The Japanese pharmaceutical market is entering a pivotal period of change. Although it is unlikely to see high growth before 2011, visiongain expects significant company activity as Japanese pharmaceutical companies strive towards international competitiveness. Global pharmaceutical companies have already begun to take advantage of the changing regulatory and economic conditions in Japan. The following five years will see further mergers and acquisitions as already demonstrated by the leading companies within Japan.

The Leading Pharmaceutical Companies Within Japan

  1. Takeda
  2. Astellas
  3. Daiichi Sankyo
  4. Pfizer
  5. Roche (Chugai)
  6. Eisai
  7. Dainippon Sumitomo
  8. Novartis
  9. Taisho
  10. Mitsubishi Pharma


Why you should buy this report

Table of Contents

  • 1. Executive Summary
  • 2 Introduction
  • 3. A Brief Insight into the Japanese Economy and Culture of Business
  • 4. An Overview of the Japanese Pharmaceutical Market
  • 4.1 Japan’s Place in the World Pharmaceutical Market
  • 5. Top Ten Japanese Pharmaceutical Companies
  • 6. Global Pharmaceutical Companies in Japan
  • 7. The Japanese Patent System
  • 7.1 A Patent System of Constant Change
  • 8. Pricing and Reimbursement in Japan
  • 8.1 The Japanese Healthcare System
  • 9. Generic Pharmaceuticals in Japan
  • 9.1 Generic Drugs Have Low Japanese Market Share
  • 10. Conclusion
  • List of Figures
  • Figure 1.1, Total Revenue ($bn) of the Japanese Pharmaceutical Market 2000- 2005
  • Figure 4.1, Pharmaceutical Market Share By Country, 2005
  • Figure 4.2, Drug Expenditure ($ per person) by Country, 2005
  • Figure 4.3, Health Expenditure by Country (% GDP), 2004
  • Figure 4.4, Market Share of Japanese Pharmaceutical Market by Therapeutic Category, 2004
  • Figure 4.5, Forecast ($bn) for the Japanese Pharmaceutical Market, 2006- 2011
  • Figure 5.1, Percentage of Takeda’s Japanese Revenue From Takeda’s Leading Drugs, 2004
  • Figure 5.2, Percentage of Astellas’ Japanese Revenue From Takeda’s Leading Drugs, 2004
  • Figure 6.1, Revenue of the Leading Pharmaceutical Companies in Japan, 2005
  • Figure 10.1, Total Revenue ($bn) of the Japanese Pharmaceutical Market, 2004- 2011
  • Figure 10.2, Total Revenue ($bn) of the Japanese Pharmaceutical Market, 2000-2011
  • List of Tables
  • Table 4.1, Pharmaceutical Market Value ($bn) for the Major Pharmaceutical Markets, 1-Year to June 2005
  • Table 4.2, Pharmaceutical Market Value ($bn) and Market Share (%) for the Major Pharmaceutical Markets, 1-Year to June 2005
  • Table 4.3, Average Pharmaceutical Expenditure Per Person for the Major Pharmaceutical Markets, 2004-2005
  • Table 4.4, Health Expenditure and Drug Expenditure Growth Rates (%) for the Major Pharmaceutical Markets, 2004-2005
  • Table 4.5, Ratio of Healthcare Expenditure to Drug Expenditure, 2004-2005
  • Table 4.6, Expenditure on Health for the Major Pharmaceutical Markets, 2004
  • Table 4.7, Growth Rate (%) of the Major Pharmaceutical Markets
  • Table 4.8, Branded and Generic Japanese Pharmaceutical Market Share, 2003
  • Table 4.9, Japanese Market Revenues ($m) and growth Rate (%) by Therapeutic Area, 2004
  • Table 4.10, Japanese Market Revenues ($m) and Market Share (%) by Therapeutic Area, 2004
  • Table 5.1, Revenue ($bn), Growth Rate (%) and Japanese Market Share (%) of the Top Ten Japanese Pharmaceutical Companies, 2004
  • Table 5.2, Total Revenue ($bn) and Net Income ($bn) for Takeda, 2004
  • Table 5.3, Key Financial Figures for Takeda, 2004
  • Table 5.4, Japanese Revenues ($m) for Takeda’s Leading Drugs, 2004
  • Table 5.5, Takeda Pipeline Products, 2005
  • Table 5.6, Total Revenue ($m) and Japanese Market Share (%) for Astellas
  • Table 5.7, Revenue ($m) of Astellas Leading Products By Originator Company, 2004
  • Table 5.8, Regional Revenue ($m) for Yamanouchi and Fujisawa, 2004
  • Table 5.9, Revenue ($bn) and Japanese Market Share (%) for Astellas, 2004
  • Table 5.10, Key Financials for Astellas, 2004
  • Table 5.11, Astellas Pipeline Products
  • Table 5.12, Daiichi Sankyo Leading Products By Originator Company, 2004
  • Table 5.13, Daiichi Sankyo Pharmaceutical Healthcare (OTC) Products By Originator Company, 2004
  • Table 5.14, Combined Revenue ($bn) and Operating Income ($bn) for Daiichi Sankyo, 2004
  • Table 5.15, Key Financials for Daiichi Sankyo
  • Table 5.16, Daiichi Sankyo Pipeline Products
  • Table 5.17, Revenue ($m) of the Top 20 Pharmaceutical Products in Japan, 2004
  • Table 6.1, Revenue ($m) from the Top Ten Pharmaceutical Companies in Japan
  • Table 6.2, Comparison of Pfizer and Chugai Pharmaceutical, 2005-12-19
  • Table 6.3, Key Financial Figures for Roche, MAT June 2005
  • Table 9.1, Generic Market Share by Volume and Value, 2005
  • Table 9.2, Revenue ($m) and Exposure (%) to Generic Competition Facing the Top Five Japanese Pharmaceutical Companies, 2006
  • Table 9.3, Japanese Generic Manufacturing Companies
  • Other users found this report page using the following search terms: japan japanese pharmaceutical market pharmaceutical japan japanese companies market pharma top industry company list

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.

    All reports are subject to copyright